<DOC>
	<DOCNO>NCT00380393</DOCNO>
	<brief_summary>This phase IIb trial do find RTS , S/AS01 vaccine help prevent child fall ill malaria evaluate vaccine safety . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Efficacy RTS , S/AS01 Vaccine Against Episodes Malaria Due P. Falciparum Infection Children .</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female child 5 month 17 month age time first vaccination . Written oral , sign thumbprinted witness informed consent obtain parent ( ) /guardian ( ) child.. Subjects investigator believe parents/guardians comply requirement protocol . Acute disease time enrolment . Serious acute chronic illness determine clinical physical examination laboratory screen test . Laboratory screen test haemoglobin , total white cell count , platelet , ALT creatinine acceptable limit . Planned administration/administration vaccine foreseen study within 30 day first dose vaccine ( ) exception tetanus toxoid schedule diphtheria , pertussis measles vaccine . Use investigational nonregistered drug vaccine within 30 day precede first dose study vaccine , plan use study period . Administration immunoglobulins , blood transfusion blood product within three month precede first dose study vaccine plan administration study period . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within 6 month prior first vaccine dose Previous participation malaria vaccine trial . Simultaneous participation clinical trial . Same sex twin . History allergic reaction ( significant IgEmediated event ) anaphylaxis previous immunization . History allergic disease reaction likely exacerbate component vaccine . Any finding investigator feel would increase risk adverse outcome participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>5 Months</minimum_age>
	<maximum_age>17 Months</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium</keyword>
	<keyword>RTS</keyword>
	<keyword>S/AS01</keyword>
	<keyword>Falciparum</keyword>
</DOC>